Skyhawk Therapeutics

About:

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

Website: https://www.skyhawktx.com/

Twitter/X: Skyhawk_Tx

Top Investors: Alexandria Venture Investments, Fidelity, Good Growth Capital, GreatPoint Ventures, Agent Capital

Description:

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.The company's therapeutics use proprietary technology that helps the rational design of small molecules that target specific binding pocket regions on RNA, using both sequence and structural specificity, at particular moments in the RNA splicing process, enabling physicians to target diseases driven by a type of RNA mis-splicing called exon skipping.

Total Funding Amount:

$181M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)skyhawktx.com

Founders:

Bill Haney, Kathleen McCarthy

Number of Employees:

51-100

Last Funding Date:

2021-09-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai